CONMED Corp — Director's Dealing 2023

Dec 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-12-04

Reporting Person: Peters Stanley W III (President AS and AET)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-04	Common Stock	M	2300	$41.93	Acquired	2363	Direct
2023-12-04	Common Stock	S	2300	$109.9276	Disposed	63	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-04	Options To Purchase Common Stock	$41.93	M	2300	Disposed	2027-03-01	Common Stock (2300)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.91 to $109.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.